Karsten Gravdal

1.6k total citations
28 papers, 1.2k citations indexed

About

Karsten Gravdal is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Karsten Gravdal has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Karsten Gravdal's work include Prostate Cancer Treatment and Research (14 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Cancer Cells and Metastasis (4 papers). Karsten Gravdal is often cited by papers focused on Prostate Cancer Treatment and Research (14 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Cancer Cells and Metastasis (4 papers). Karsten Gravdal collaborates with scholars based in Norway, United States and Netherlands. Karsten Gravdal's co-authors include Lars A. Akslen, Ole J. Halvorsen, Svein A. Haukaas, Christian Beisland, Randolph S. Watnick, Nandita Bhattacharya, Suming Wang, Diane R. Bielenberg, Vivek Mittal and Tina El Rayes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Karsten Gravdal

26 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karsten Gravdal Norway 16 620 465 354 330 133 28 1.2k
Pamela Villalobos United States 18 598 1.0× 621 1.3× 350 1.0× 329 1.0× 161 1.2× 27 1.3k
Marianna Gallo Italy 18 588 0.9× 693 1.5× 328 0.9× 319 1.0× 123 0.9× 37 1.3k
Lian Xu China 17 475 0.8× 449 1.0× 314 0.9× 316 1.0× 145 1.1× 40 1.1k
Isa Mambetsariev United States 17 467 0.8× 370 0.8× 470 1.3× 269 0.8× 87 0.7× 70 1.1k
Naohiro Uraoka Japan 18 602 1.0× 484 1.0× 210 0.6× 330 1.0× 149 1.1× 48 1.1k
Andrea Malfettone Spain 23 705 1.1× 664 1.4× 321 0.9× 358 1.1× 206 1.5× 53 1.5k
Qingfu Zhang China 22 816 1.3× 377 0.8× 376 1.1× 531 1.6× 128 1.0× 63 1.4k
Véronique Ouellet Canada 22 770 1.2× 493 1.1× 205 0.6× 314 1.0× 208 1.6× 47 1.4k
David Balli United States 16 764 1.2× 826 1.8× 464 1.3× 360 1.1× 264 2.0× 31 1.6k
Zhenfang Du China 15 776 1.3× 404 0.9× 279 0.8× 227 0.7× 105 0.8× 34 1.3k

Countries citing papers authored by Karsten Gravdal

Since Specialization
Citations

This map shows the geographic impact of Karsten Gravdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karsten Gravdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karsten Gravdal more than expected).

Fields of papers citing papers by Karsten Gravdal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karsten Gravdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karsten Gravdal. The network helps show where Karsten Gravdal may publish in the future.

Co-authorship network of co-authors of Karsten Gravdal

This figure shows the co-authorship network connecting the top 25 collaborators of Karsten Gravdal. A scholar is included among the top collaborators of Karsten Gravdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karsten Gravdal. Karsten Gravdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Helle, Svein Inge, Lars A. R. Reisæter, L.B. Hysing, et al.. (2024). Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up. Journal of Clinical Oncology. 42(16). 1934–1942. 6 indexed citations
3.
Helle, Svein Inge, et al.. (2024). Reply to M. Kamrava and F. Montorsi et al. Journal of Clinical Oncology. 42(35). 4234–4235.
4.
Juliebø‐Jones, Patrick, et al.. (2023). Transitioning from transrectal to transperineal prostate biopsy using a freehand cognitive approach. British Journal of Urology. 133(3). 324–331. 7 indexed citations
5.
Reisæter, Lars A. R., Jurgen J. Fütterer, Are Losnegård, et al.. (2017). Optimising preoperative risk stratification tools for prostate cancer using mpMRI. European Radiology. 28(3). 1016–1026. 18 indexed citations
6.
Gravdal, Karsten, et al.. (2017). Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma. Acta Ophthalmologica. 96(1). 31–38. 40 indexed citations
7.
Wang, Suming, Anna Blois, Tina El Rayes, et al.. (2016). Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment. Science Translational Medicine. 8(329). 329ra34–329ra34. 50 indexed citations
9.
Haukaas, Svein A., Geir Egil Eide, Ole J. Halvorsen, et al.. (2014). Prostate cancer antigen-3 (PCA3) and PCA3-based nomograms in the diagnosis of prostate cancer: an external validation of Hansen’s nomogram on a Norwegian cohort. Scandinavian Journal of Urology. 49(1). 8–15. 7 indexed citations
10.
Li, Wenliang, Nanping Ai, Suming Wang, et al.. (2014). GRK3 is essential for metastatic cells and promotes prostate tumor progression. Proceedings of the National Academy of Sciences. 111(4). 1521–1526. 36 indexed citations
11.
Catena, Raúl, Nandita Bhattacharya, Tina El Rayes, et al.. (2013). Bone Marrow–Derived Gr1+ Cells Can Generate a Metastasis-Resistant Microenvironment Via Induced Secretion of Thrombospondin-1. Cancer Discovery. 3(5). 578–589. 102 indexed citations
12.
Haukaas, Svein A., et al.. (2013). A positive real‐time elastography is an independent marker for detection of high‐risk prostate cancers in the primary biopsy setting. British Journal of Urology. 113(5b). E90–7. 17 indexed citations
13.
Straume, Anne Hege, Kristian Løvås, Hrvoje Miletić, et al.. (2012). Elevated levels of the steroidogenic factor 1 are associated with over-expression of CYP19 in an oestrogen-producing testicular Leydig cell tumour. European Journal of Endocrinology. 166(5). 941–949. 12 indexed citations
14.
Haukaas, Svein A., et al.. (2012). Combination of real-time elastography and urine prostate cancer gene 3 (PCA3) detects more than 97% of significant prostate cancers. Scandinavian Journal of Urology. 47(3). 211–216. 10 indexed citations
15.
Gravdal, Karsten, et al.. (2012). Lethal pneumonitis after docetaxel chemotherapy: Case report and review of the literature. Acta Oncologica. 52(5). 1034–1038. 7 indexed citations
16.
Olsen, Jan Roger, Xisong Ke, Kari Rostad, et al.. (2012). Abstract 1290: The ability of the transcription factor p63 to induce selected gene expression modules associated with mesenchymal to epithelial transition of prostate cells. Cancer Research. 72(8_Supplement). 1290–1290. 1 indexed citations
17.
Fluge, Øystein, Karsten Gravdal, Erik Carlsen, et al.. (2009). Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. British Journal of Cancer. 101(8). 1282–1289. 123 indexed citations
18.
Lin, Biaoyang, Angelita G. Utleg, Karsten Gravdal, et al.. (2008). WDR19 Expression is Increased in Prostate Cancer Compared with Normal Cells, but Low-Intensity Expression in Cancers is Associated with Shorter Time to Biochemical Failures and Local Recurrence. Clinical Cancer Research. 14(5). 1397–1406. 15 indexed citations
19.
Ellingsen, Ivar, et al.. (2005). 3-D endobronchial ultrasonography—A post mortem study. Ultrasound in Medicine & Biology. 31(4). 473–476. 5 indexed citations
20.
Gravdal, Karsten, Ole J. Halvorsen, Svein A. Haukaas, & Lars A. Akslen. (2005). Expression of bFGF/FGFR-1 and vascular proliferation related to clinicopathologic features and tumor progress in localized prostate cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 448(1). 68–74. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026